On Jun 29, 2018 34.99 % to Target, Endo International (NASDAQ:ENDP) Stock “Buy” Rating Kept by B. Riley FBR.

June 29, 2018 - By Noel Courtney

Endo International plc (NASDAQ:ENDP) Corporate Logo

Big Money Sentiment decreased to 1.07 in Q1 2018. It has change of 0.06, from 2017Q4’s 1.13. The ratio turned negative due to Endo International plc positioning: 25 sold and 70 reduced. 33 funds took stakes and 69 increased stakes. Investors holded 203.77 million in 2017Q4 but now own 213.17 million shares or 4.61% more.

Rhumbline Advisers holds 0% or 342,001 shs in its capital. Aqr Cap Mgmt invested 0.03% in Endo International plc (NASDAQ:ENDP). 41,421 were accumulated by Utah Retirement System. Amalgamated Bankshares accumulated 0.01% or 44,344 shs. Stratos Wealth Partners stated it has 0% in Endo International plc (NASDAQ:ENDP). Fincl Architects, a New Jersey-based fund reported 2,000 shs. Gsa Prtnrs Llp holds 12,993 shs. Tci Wealth Advisors Inc holds 0.04% or 15,077 shs in its capital. Dekabank Deutsche Girozentrale invested 0% of its capital in Endo International plc (NASDAQ:ENDP). Moreover, Invesco has 0.01% invested in Endo International plc (NASDAQ:ENDP) for 2.82M shs. 21.20M were reported by Blackrock. Legal And General Gru Public Ltd Company reported 414,456 shs. Liberty Mutual Grp Inc Asset Mgmt Inc holds 39,580 shs or 0.01% of its capital. Ajo Lp has invested 0.04% in Endo International plc (NASDAQ:ENDP). 41,870 were accumulated by Public Employees Retirement Association Of Colorado.

Reiterated Endo International (NASDAQ:ENDP) Rating.

New York: On Thursday morning, a research note was revealed to investors and clients of Endo International (NASDAQ:ENDP). Its “Buy” Rating maintained at B. Riley FBR. Research analysts have TP of $13 which indicates 34.99 % upside potential on firm’s stock.

Endo International plc (NASDAQ:ENDP) Ratings Coverage

In total 11 analysts cover Endo International (NASDAQ:ENDP). “Buy” rating has 3, “Sell” are 0, while 8 are “Hold”. 27% are bullish. 14 are the (NASDAQ:ENDP)’s analyst reports since January 3, 2018 according to StockzIntelligence Inc. On Wednesday, February 28 Gabelli downgraded Endo International plc (NASDAQ:ENDP) to “Hold” rating. On Wednesday, January 3 Mizuho maintained Endo International plc (NASDAQ:ENDP) rating. Mizuho has “Buy” rating and $12.0 target. On Wednesday, February 28 the company was maintained by William Blair. In Monday, March 5 report BMO Capital Markets maintained it with “Market Perform” rating and $9 target. On Wednesday, February 21 Canaccord Genuity maintained Endo International plc (NASDAQ:ENDP) rating. Canaccord Genuity has “Hold” rating and $7 target. On Monday, February 26 the firm earned “Market Perform” rating by JMP Securities. On Thursday, June 28 the firm earned “Buy” rating by FBR Capital. On Wednesday, June 27 Citigroup upgraded the shares of ENDP in report to “Buy” rating. On Wednesday, April 4 the rating was downgraded by Mizuho to “Neutral”. In Tuesday, January 2 report Stifel Nicolaus maintained the stock with “Hold” rating.

Ticker’s shares touched $9.63 during the last trading session after 2.03% change.Endo International plc has volume of 3.02M shares. Since June 29, 2017 ENDP has declined 51.05% and is downtrending. ENDP underperformed by 63.62% the S&P500.

Endo International plc (NASDAQ:ENDP)’s quarterly earnings will be published on August, 14., according to Faxor. The EPS diference is $0.39 or 41.94 % down from last years number. Previous year: $0.93; Analysts forcast: $0.54. The profit will be $120.84M for ENDP if $0.54 EPS becomes true. Last quarter $0.67 EPS was reported. Analysts sees -19.40 % negative EPS growth this quarter.

Endo International plc, a specialty pharmaceutical company, makes and sells generic and branded pharmaceuticals in the United States, Canada, and internationally.The firm is worth $2.16 billion. The firm operates through three divisions: U.S.Currently it has negative earnings. Generic Pharmaceuticals, U.S.

For more Endo International plc (NASDAQ:ENDP) news brought out recently go to: Seekingalpha.com, Benzinga.com, Fool.com, Profitconfidential.com or Streetinsider.com. The titles are as follows: “Buy Alibaba – Cramer’s Lightning Round (6/12/18)” brought out on June 13, 2018, “Endo Wins Citi Upgrade On Positive Catalysts, Cellulite Treatment Opportunity” on June 27, 2018, “Why Endo International plc Rocketed Higher Today” with a publish date: June 06, 2018, “These Indications Suggest That ENDP Stock Has Finally Found a Bottom” and the last “Endo (ENDP) Reports Master Settlement Agreement Allowing for Resolution of Known Testosterone Replacement …” with publication date: June 11, 2018.

Endo International plc (NASDAQ:ENDP) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: